The P/E ratio for Integra Lifesciences Holdings stock stands at 33.34 as of Apr 26, 2024. This takes into account the latest EPS of $0.85 and stock price of $28.34. The PE ratio at present is nearly equal to the average from the previous 4 quarters.
Over the last ten years, the average PE ratio of Integra Lifesciences Holdings has been 128.43. The current 33.34 price-to-earnings ratio is 74% less than the historical average. Analyzing the last ten years, IART's PE ratio reached its highest point in the Sep 2015 quarter at 1,489, with a price of $29.78 and an EPS of $0.02. The Sep 2022 quarter saw the lowest point at 20.46, with a price of $42.36 and an EPS of $2.07.
Maximum annual increase: 99.22% in 2023
Maximum annual decrease: -58.4% in 2020
Year | PE ratio | Change |
---|---|---|
2023 | 51.24 | 99.22% |
2022 | 25.72 | -23.22% |
2021 | 33.5 | -18.47% |
2020 | 41.09 | -58.4% |
2019 | 98.78 | 59.89% |
2018 | 61.78 | 8.42% |
2017 | 56.98 | 32.82% |
2016 | 42.9 | N/A |
2015 | N/A | N/A |
2014 | 52.14 | N/A |
The current PE ratio of IART is above its 3-year average, but it is under its 5 and 10-year averages.
When compared to its peers SYK and CAH, IART's PE ratio is lower, but it is higher than JNJ's and MDT's. Integra Lifesciences Holdings's current PE ratio of 33.34 is more than the average of its peers, which is 27.99.
Stock name | PE ratio | Market cap |
---|---|---|
JNJ Johnson & Johnson | 10.53 | $352.02B |
CNMD CONMED Corp | 24.45 | $2.03B |
MDT Medtronic plc | 25.31 | $105.88B |
TFX Teleflex Inc | 27.27 | $9.73B |
IART Integra Lifesciences Holdings Corp | 33.34 | $2.22B |
CAH Cardinal Health Inc | 40.16 | $25.1B |
SYK Stryker Corp | 40.24 | $127.62B |
XRAY DENTSPLY SIRONA Inc | N/A | $6.34B |
As of Apr 26, 2024, IART stock has a price to earnings ratio of 33.34.
Over the last 3 years, the average PE ratio for IART stock is 30.23.
Over the last 5 years, the average PE ratio for IART stock is 47.13.
Over the last ten years, the quarterly PE ratio reached its highest level at 1,489 in the Sep 2015 quarter.
IART's price to earnings ratio is currently 74% below its 10-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Apr 26, 2024), Integra Lifesciences Holdings's share price is $28.34. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $0.85. Therefore, Integra Lifesciences Holdings's price to earnings ratio for today is 33.34. PE RATIO(33.34) = STOCK PRICE($28.34) / TTM EPS($0.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.